DNA X, Inc. (SONM)
NASDAQ
3.15
+0.05 (+1.61%)
Closed
Oct 14, 2026
Day's Range
3.153.20
52 wk Range
2.5216.97
Financial Statements - SONM - DNA X, Inc.
Revenue
0▼ 100.0%
Net Income
-20.65M▲ 38.6%
EBITDA
-2.00M▲ 92.2%
Free Cash Flow
-23.52M▼ 170.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 58.29M | 93.63M | 69.82M | 54.57M | 63.99M |
| Cost of Goods | 0 | 48.37M | 74.30M | 58.20M | 48.15M | 48.78M |
| Gross Profit | 0 | 9.92M | 19.32M | 11.62M | 6.41M | 15.21M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -5.40M | -29.66M | 513K | -14.29M | -38M | -27.71M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -1.06M | -3.73M | -214K | 484K | -459K | -1.98M |
| Pre Tax Income | -7.95M | -33.42M | 284K | -13.90M | -38.46M | -30.45M |
| Income Tax | 0 | 226K | 374K | 184K | 167K | -521K |
| Net Income | -20.65M | -33.64M | -90K | -14.08M | -38.62M | -29.93M |
| EPS Basic | -28.58 | -7.13 | -0.021588 | -4.9 | -40.8 | -64.8 |
| EPS Diluted | -28.58 | -7.13 | -0.021588 | -4.9 | -40.8 | -64.8 |
| Basic Shares Outstanding | 722.68K | 4.71M | 4.16M | 2.88M | 946.45K | 462.08K |
| Diluted Shares Outstanding | 722.68K | 4.71M | 4.16M | 2.88M | 946.45K | 462.08K |
| Ebit | -6.46M | -33.39M | 299K | -13.80M | -38.46M | -29.69M |
| Ebitda | -2M | -25.85M | 2.50M | -11.43M | -36.33M | -25.42M |
| Net Income Continuous Operations | -20.65M | -33.64M | -90K | -14.08M | -38.62M | -29.93M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
